SNOW

Prezzo Snowflake

Closed
SNOW
$142,56
-$1,69(-1,17%)

*Data last updated: 2026-04-29 00:33 (UTC+8)

As of 2026-04-29 00:33, Snowflake (SNOW) is priced at $142,56, with a total market cap of $49,28B, a P/E ratio of -48,83, and a dividend yield of 0,00%. Today, the stock price fluctuated between $141,46 and $146,42. The current price is 0,77% above the day's low and 2,63% below the day's high, with a trading volume of 3,48M. Over the past 52 weeks, SNOW has traded between $118,30 to $280,67, and the current price is -49,20% away from the 52-week high.

SNOW Key Stats

Yesterday's Close$144,25
Market Cap$49,28B
Volume3,48M
P/E Ratio-48,83
Dividend Yield (TTM)0,00%
Diluted EPS (TTM)3,90
Net Income (FY)-$1,33B
Revenue (FY)$4,68B
Earnings Date2026-05-27
EPS Estimate0,32
Revenue Estimate$1,32B
Shares Outstanding341,64M
Beta (1Y)1.228

About SNOW

Snowflake Inc. provides a cloud-based data platform in the United States and internationally. The company's platform offers Data Cloud, which enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of sizes in a range of industries. The company was formerly known as Snowflake Computing, Inc. and changed its name to Snowflake Inc. in April 2019. Snowflake Inc. was incorporated in 2012 and is based in Bozeman, Montana.
SectorTechnology
IndustrySoftware - Application
CEOSridhar Ramaswamy
HeadquartersBozeman,MT,US
Employees (FY)9,06K
Average Revenue (1Y)$516,99K
Net Income per Employee-$146,97K

Snowflake (SNOW) FAQ

What's the stock price of Snowflake (SNOW) today?

x
Snowflake (SNOW) is currently trading at $142,56, with a 24h change of -1,17%. The 52-week trading range is $118,30–$280,67.

What are the 52-week high and low prices for Snowflake (SNOW)?

x

What is the price-to-earnings (P/E) ratio of Snowflake (SNOW)? What does it indicate?

x

What is the market cap of Snowflake (SNOW)?

x

What is the most recent quarterly earnings per share (EPS) for Snowflake (SNOW)?

x

Should you buy or sell Snowflake (SNOW) now?

x

What factors can affect the stock price of Snowflake (SNOW)?

x

How to buy Snowflake (SNOW) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Snowflake (SNOW)

SelfRugger

SelfRugger

8 ore fa
This is a paid press release. Contact the press release distributor directly with any inquiries. Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) =================================================================================== Business Wire Thu, February 19, 2026 at 6:01 AM GMT+9 2 min read In this article: STOK -0.35% **BEDFORD, Mass., February 18, 2026**--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on February 17, 2026, it granted stock options to purchase an aggregate of 22,950 shares of common stock to five new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options that were granted have an exercise price of $31.09 per share, which is equal to the closing price of Stoke’s common stock on February 17, 2026. Each option will vest over a 4-year period, with 1/4th of the shares underlying the employee’s option vesting on the one-year anniversary of the applicable vesting commencement date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying each employee’s option over the following 36 months, subject to the employee’s continued employment with Stoke on such vesting dates. The options have a term of 10 years and are subject to the terms and conditions of the 2023 Inducement Plan and the stock option agreement covering the grant. **About Stoke Therapeutics **Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit View source version on businesswire.com: **Contacts** **Stoke Media & Investor Contacts: ** Susan Willson Vice President, Corporate Communications swillson@stoketherapeutics.com 415-509-8202 Doug Snow Director, Communications & Investor Relations IR@stoketherapeutics.com 508-642-6485 Terms and Privacy Policy Privacy Dashboard More Info
0
0
0
0
SelfRugger

SelfRugger

19 ore fa
This is a paid press release. Contact the press release distributor directly with any inquiries. Alterra Mountain Company Appoints David Flueck as Chief Customer Officer and President, Ikon Pass ================================================================================================= Business Wire Thu, February 19, 2026 at 4:15 AM GMT+9 3 min read In this article: MAR -0.79% **DENVER, February 18, 2026**--(BUSINESS WIRE)--Alterra Mountain Company today announced the appointment of David Flueck as Chief Customer Officer and President, Ikon Pass. With over two decades of experience in travel and hospitality, David will lead the company’s customer engagement strategy as well as its sales, marketing, and communications functions. David’s appointment reinforces Alterra’s commitment to delivering industry-leading hospitality experiences by building meaningful connections between its guests and their favorite mountain destinations. In his new role, David will steward the continued growth of Alterra’s flagship product, Ikon Pass, further cementing its position as the premier multi-destination ski and snowboard pass, while expanding its potential as a gateway to year-round adventures. Most recently, David served as Global Officer of Loyalty, Cards, and New Businesses at Marriott International. There, he created and led the Marriott BonvoyTM loyalty program, which serves more than 270 million travelers worldwide. He also developed an industry-leading global loyalty ecosystem with 31 credit cards and over 60 partnerships. David spearheaded several of Marriott’s new ventures, including Marriott Bonvoy Outdoors and Marriott Bonvoy Boutiques. Under his leadership, Marriott Bonvoy evolved through strategic partnerships and distinctive experiences, establishing it as one of the world’s leading loyalty programs. "David is a world-class travel and hospitality executive whose extensive experience will help guide the next phase of Alterra Mountain Company's development," said Jared Smith, President & CEO, Alterra Mountain Company. "We feel extremely fortunate to add David to our team as we continue to build a unique company driven by our mission to shape the future of mountain adventure for generations to come." Originally from Boulder, Colorado, David is a passionate skier who spends his free time outdoors skiing, mountain biking, and exploring new places. "I am incredibly excited to join the team at Alterra Mountain Company and combine my hospitality experience with my passion for the outdoors," said David Flueck, Chief Customer Officer and President, Ikon Pass, Alterra Mountain Company. "I look forward to helping shape the future of mountain adventure, and building rewarding and extraordinary experiences that inspire and connect guests to our remarkable destinations." **About Alterra Mountain Company** Alterra Mountain Company is a family of iconic year-round mountain destinations, the world’s largest heli-skiing operation, and Ikon Pass - the premier ski and snowboard season pass offering access to more than 70 iconic mountain destinations around the world. Headquartered in Denver, Colorado and born out of a shared love of the mountains and adventure, the company has brought together some of the world’s most aspirational brands, including: Steamboat, Winter Park and Arapahoe Basin in Colorado; Palisades Tahoe, Mammoth Mountain, June Mountain, Big Bear Mountain Resort and Snow Valley in California; Stratton Mountain and Sugarbush Resort in Vermont; Snowshoe Mountain in West Virginia; Tremblant in Quebec and Blue Mountain in Ontario, Canada; Crystal Mountain in Washington; Schweitzer in Idaho; Deer Valley Resort and Solitude Mountain Resort in Utah; CMH Heli-Skiing & Summer Adventures and Mike Wiegele Helicopter Skiing in British Columbia. Also included in the portfolio are Alpine Aerotech, a worldwide helicopter support and maintenance service center in British Columbia, Canada, Aspenware, the ski industry leader in technology services and e-commerce, and Ski Butlers, the global leader in ski and snowboard rental delivery. For more information, please visit www.alterramtn.co. Story Continues View source version on businesswire.com: **Contacts** Amelie Bruzat The Ashima Group amelie@theashimagroup.com Terms and Privacy Policy Privacy Dashboard More Info
0
0
0
0